Article Information
PubMed
Print ISSN
Online ISSN
History
- Published online June 21, 2021.
Article Versions
- You are currently viewing an Earlier version of this article (June 21, 2021 - 13:16).
- earlier version (June 29, 2021 - 09:42).
- View the most recent version of this article
Copyright & Usage
© 2020 The Authors. This is an open access article under the terms of the Creative Commons Attribution Non-Commercial License, which permits use, distribution, and reproduction in any medium, provided that the original work is properly cited and is not used for commercial purposes.
Author Information
- Saeho Chong1,
- Sagar Agarwal2,
- Saket Agarwal3,
- Krishna C. Aluri4,
- Michael Arciprete5,
- Christopher Brown6,
- Klaus Charisse7,
- Joseph Cichocki8,
- Kevin Fitzgerald9,
- Varun Goel10,
- Yongli Gu11,
- Dale Guenther12,
- Bahru Habtemariam2,
- Vasant Jadhav6,
- Maja Janas3,
- Muthusamy Jayaraman13,
- Jeff Kurz14,
- Jing Li5,
- Steven Liou14,
- Ju Liu5,
- Xiumin Liu14,
- Christopher Maclauchlin14,
- Martin Maier14,
- Muthiah Manoharan9,
- Robin McDougall1,
- Jay Nair7,
- Diane Ramsden15,
- Gabriel Robbie2,
- Karyn Schmidt6,
- Peter Smith5,
- Christopher Theile7,
- Akshay Vaishnaw9,
- Scott Waldron9,
- Jing-Tao Wu16,*,
- Yuanxin Xu5,
- Xuemei Zhang5,
- Ivan Zlatev7, and
- Elena castellanos-Rizaldos6
- 1Drug Metabolism and Pharmacokinetics, Alnylam Pharmaceuticals Inc., United States
- 2Clinical Pharmacology, Alnylam Pharmaceuticals, United States
- 3Investigative Toxicology, Alnylam Pharmaceuticals, United States
- 4Early Development, Alnylam pharmaceuticals, United States
- 5Alnylam Pharmaceuticals Inc., United States
- 6Biology, Alnylam Pharmaceuticals, United States
- 7Chemistry, Alnylam Pharmaceuticals, United States
- 8Toxicology, Vertex Pharmaceuticals, United States
- 9Research, Alnylam Pharmaceuticals, United States
- 10Clinical Pharmacology, Avidity Bioscience, United States
- 11Bioanalytical Science, Alnylam Pharmaceuticals, United States
- 12RNAi Discovery, Alnylam Pharmaceuticals, United States
- 13CRISPR Therapeutics, United States
- 14DMPK, Alnylam Pharmaceuticals, United States
- 15DMPK, Takeda, United States
- 16DMPK, Alnylam, United States
- ↵* Corresponding Author:
Jing-Tao Wu, DMPK, Alnylam, 300 Third Street, Cambridge, 2142, United States. E-mail: jtwu{at}alnylam.com